0000904454-14-000115.txt : 20140129
0000904454-14-000115.hdr.sgml : 20140129
20140129205517
ACCESSION NUMBER: 0000904454-14-000115
CONFORMED SUBMISSION TYPE: 3
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20140129
FILED AS OF DATE: 20140129
DATE AS OF CHANGE: 20140129
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Dicerna Pharmaceuticals Inc
CENTRAL INDEX KEY: 0001399529
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 480 ARSENAL ST. BUILDING 1, SUITE 120
CITY: WATERTOWN
STATE: MA
ZIP: 02472
BUSINESS PHONE: 617 621 8097
MAIL ADDRESS:
STREET 1: 480 ARSENAL ST. BUILDING 1, SUITE 120
CITY: WATERTOWN
STATE: MA
ZIP: 02472
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: DOVEY BRIAN H
CENTRAL INDEX KEY: 0001207786
FILING VALUES:
FORM TYPE: 3
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36281
FILM NUMBER: 14558442
MAIL ADDRESS:
STREET 1: ONE PALMER SQUARE
CITY: PRINCETON
STATE: NJ
ZIP: 08542
3
1
edgar.xml
PRIMARY DOCUMENT
X0206
3
2014-01-29
0
0001399529
Dicerna Pharmaceuticals Inc
DRNA
0001207786
DOVEY BRIAN H
C/O DOMAIN ASSOCIATES, LLC
ONE PALMER SQUARE
PRINCETON
NJ
08542
0
0
1
0
Series B Preferred Stock
Common Stock
476464
I
By Domain Partners VIII, L.P.
Series C Preferred Stock
Common Stock
1276243
I
By Domain Partners VIII, L.P.
Warrant
7.00
2014-01-29
2018-06-26
Series C Preferred Stock
21041
I
By Domain Partners VIII, L.P.
Series B Preferred Stock
Common Stock
3535
I
By DP VIII Associates, L.P.
Series C Preferred Stock
Common Stock
9469
I
By DP VIII Associates, L.P.
Warrant
7.00
2014-01-29
2018-06-26
Series C Preferred Stock
156
I
By DP VIII Associates, L.P.
All outstanding Preferred Stock will automatically convert into Common Stock upon the closing of the Issuer's initial public offering (the "IPO"), for no additional consideration. The Preferred Stock has no expiration date.
The Reporting Person is a Managing Member of One Palmer Square Associates VIII, LLC, which is the sole general partner of Domain Partners VIII, L.P. and DP VIII Associates, L.P. Pursuant to Instruction (5)(b)(iv) of Form 3, the Reporting Person has elected to report as indirectly beneficially owned the entire number of securities beneficially owned by each such entity. The Reporting Person disclaims beneficial ownership of any securities, and any proceeds thereof, that exceed his or her pecuniary interest therein and/or that are not actually distributed to him or her.
/s/ Kathleen K. Schoemaker, Attorney-in-Fact
2014-01-29